Register to receive a free US Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices synopsis and brochure
According to a new series of reports on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices by iData Research, the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable manufacturer equipment (DME) realm. Beginning in January of 2016, the U.S. Congress dramatically cut reimbursement for home oxygen services by applying competitive rates in geographic areas that were previously excluded from competitive bidding. Some providers of home oxygen therapy have already started planning in order to stay operational in the face of such drastic shortfalls, which could result in the elimination of many of the critical services upon which patients have come to depend.
“Despite some fairly saturated markets such as anesthesia monitors and anesthesia delivery units, there are some ARS markets that are shifting dramatically due to technological improvements,” explains Dr. Kamran Zamanian, CEO of iData. “These shifts include movement away from traditional nebulizers with compressors towards more technologically advanced, ultrasonic products, including vibrating mesh nebulizers.”
Within the oxygen therapy market, there is a shift away from traditional oxygen cylinders towards more efficient and convenient portable oxygen concentrators which are also being purchased as an additional oxygen therapy device for each patient. Finally, within the realm of sleep therapy, auto-titrating devices are becoming more popular relative to the more traditional continuous positive airway pressure (CPAP) devices which do not account for changes in airflow.
The sleep apnea and oxygen therapy markets are the fastest growing segment and represent the two largest markets in the United States. These markets will grow as a result of the aging population, the increase in the number of diagnoses and related procedures. Price erosion as a result of competitive pressures such as the Competitive Bidding Program is also set to limit growth in the majority of these markets.
Philips Respironics is the leading competitor in the overall ARS market. Phillips manufactures and distributes anesthesia monitors, anesthesia information management systems (AIMS), ventilators, nebulizers, oxygen therapy equipment, PAP devices and corresponding interfaces, as well as sleep diagnostic devices. They have focused on bundling their IntelliVue® MX line of monitors with GE’s Aisys® and Drӓger’s Narkomed®/Fabius® anesthesia machines by offering a mounting kit that they sell alongside their monitor products to make them compatible with the leading anesthesia machines in the market.
ResMed holds the second leading position through the company’s major presence in the sleep therapy and diagnostic markets. ResMed acquired a significant amount of companies in order to expand its presence within certain segments, but also within certain global regions like China. Additional competitors in the U.S. ARS market include CAIRE Inc., Becton Dickinson, GE Healthcare, DeVilbiss, Invacare, Drӓger, Teleflex, Fisher & Paykel, Covidien, Inogen, Ambu, Smiths Medical, Mindray, Omron, Maquet, Westmed and Natus among others.
For Further Information
More on the anesthesia and respiratory device market in the U.S. can be found in a series of reports published by iData Research entitled the US Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices.